Drug delivery, formulation

114 Results

Flow Cytometry Services

Q2 Solutions | 01-Jun-2020 | Data Sheet

We are an established leader in flow cytometry services for clinical trials. Our technologies and solutions meet the growing global demand for enhanced...

Outsourcing Analytical Testing for Biologics - A CRO's Perspective

Frontage Laboratories | 01-Dec-2019 | Technical / White Paper

Biologics are complex large molecules derived from living organisms or manufactured from cells, and they have inherent structural heterogeneity. Indeed,...

How to Avoid Surprises in Small-Molecule Drug Development Programs

Frontage Laboratories | 01-Oct-2019 | Technical / White Paper

Over the years, the pharmaceutical industry has made steady progress in improving the safety of drugs in development. Consequently, in 2015, only 14 percent...

Validating The Simoa Technology

Frontage Laboratories | 01-Oct-2019 | Technical / White Paper

Frontage is the first and only laboratory to validate Quanterix’ Simoa HD1 Analyzer for performing immunoassays. Most of the advanced instruments used...

Assessing Pre-Existing Antibodies in Biotheraputic Development

Frontage Laboratories | 21-Aug-2019 | Technical / White Paper

Immunogenicity is the leading reason that biologics fail in clinical trials, and thus it has become imperative for drug development programs to include...

The Truth about Physician Referrals and Clinical Trials

BBK Worldwide | 24-Jul-2019 | Technical / White Paper

Despite growing evidence, the myth that physicians won’t refer patients to clinical trials persists, perpetuated by the belief that they fear losing their...

Stability Testing As a Quality Control Measure

Frontage Laboratories | 19-Jun-2019 | Technical / White Paper

Stability testing is, in essence, a quality control process and is there¬fore a vital component of every phase of clinical development for both large and...

Resupply Optimization through IRT and the Benefits of a Drug Supply Center of Excellence

Cenduit | Recorded the 31-Jan-2019 | Webinar

This case study will discuss the many challenges of re-supply optimization

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 05-Nov-2018 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

Survey Report: State of the global pharmaceutical contract services industry 2018

William Reed | 11-Jul-2018 | Research Study

In May 2018 Outsourcing-Pharma.com, in association with InnovoCommerce, conducted its second annual ‘state of the industry’ survey on its user base of...

Product Innovations

Flow Cytometry Services

We are an established leader in flow cytometry services for clinical trials. Our technologies and solutions meet the growing global demand for enhanced...

Drug delivery, formulation

114 Results

Flow Cytometry Services

Outsourcing Analytical Testing for Biologics - A CRO's Perspective

How to Avoid Surprises in Small-Molecule Drug Development Programs

Validating The Simoa Technology

Assessing Pre-Existing Antibodies in Biotheraputic Development

The Truth about Physician Referrals and Clinical Trials

Stability Testing As a Quality Control Measure

Resupply Optimization through IRT and the Benefits of a Drug Supply Center of Excellence

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Survey Report: State of the global pharmaceutical contract services industry 2018

Suppliers

Laurus Labs Ltd.

Clinical Ink

AMRI

Vetter Pharma International GmbH

Baxter BioPharma Solutions

Marken

Follow us

Related News

Product Innovations

Flow Cytometry Services

Promotional Features

Free newsletter sign up

Outsourcing-Pharma

Resources